Guillaume Martin-Blondel

Guillaume Martin-Blondel

Auto-generated profile, based on publicly available information

Guillaume Martin-Blondel

CHU Toulouse, Toulouse, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Radiology
Verified
Journal Article
Closed access
SKStéphane Kremer
Stéphane Kremer
FLFrançois Lersy
François Lersy
JSJérome de Sèze
Jérome de Sèze
JFJean-Christophe Ferré
Jean-Christophe Ferré
AMAdel Maamar
Adel Maamar
FCFrancois Cotton
Francois Cotton
Background Brain MRI parenchymal signal abnormalities have been in association with SARS-CoV-2. Purpose Describe the neuroimaging findings (excluding ischemic infarcts) in patients with severe COVI...

1 April 2016 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
JMJEAN MICHEL MANSUY
JEAN MICHEL MANSUY
MDMarine Dutertre
Marine Dutertre
CMCatherine Mengelle
Catherine Mengelle
CFCamille Fourcade
Camille Fourcade
BMBruno Marchou
Bruno Marchou
GMGuillaume Martin-Blondel
Guillaume Martin-Blondel

1 October 2016 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
JMJEAN MICHEL MANSUY
JEAN MICHEL MANSUY
ESElsa Suberbielle
Elsa Suberbielle
SCSabine Chapuy-Regaud
Sabine Chapuy-Regaud
CMCatherine Mengelle
Catherine Mengelle
LBLouis Bujan
Louis Bujan
GMGuillaume Martin-Blondel
Guillaume Martin-Blondel

18 January 2016 in Nature Reviews Neurology
Verified
Journal Article
Closed access
GMGuillaume Martin-Blondel
Guillaume Martin-Blondel
DBDavid Brassat
David Brassat
JBJan Bauer
Jan Bauer
HLHans Lassmann
Hans Lassmann
RLRoland S. Liblau
Roland S. Liblau

8 January 2010 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
AGAmandine Galès
Amandine Galès
ACAnnabelle Conduché
Annabelle Conduché
JBJosé Bernad
José Bernad
LLLise Lefevre
Lise Lefevre
David OlagnierDavid Olagnier
David Olagnier
BPBernard Pipy
Bernard Pipy
We recently showed that IL-13 or peroxisome proliferator activated receptor γ (PPARγ) ligands attenuate Candida albicans colonization of the gastrointestinal tract. Here, using a macrophage-specific Dectin-1 deficient mice model, we demonstrate that Dectin-1 is essential to control fungal gastrointestinal infection by PPARγ ligands. We also show that the phagocytosis of yeast and the release of reactive oxygen intermediates in response to Candida albicans challenge are impaired in macrophages from Dectin-1 deficient mice treated with PPARγ ligands or IL-13. Although the Mannose Receptor is not sufficient to trigger antifungal functions during the alternative activation of macrophages, our data establish the involvement of the Mannose Receptor in the initial recognition of non-opsonized Candida albicans by macrophages. We also demonstrate for the first time that the modulation of Dectin-1 expression by IL-13 involves the PPARγ signaling pathway. These findings are consistent with a crucial role for PPARγ in the alternative activation of macrophages by Th2 cytokines. Altogether these data suggest that PPARγ ligands may be of therapeutic value in esophageal and gastrointestinal candidiasis in patients severely immunocompromised or with metabolic diseases in whom the prevalence of candidiasis is considerable. Since the early 1980s, Candida albicans has emerged as major cause of human disease, especially among immunocompromised individuals and those with metabolic dysfunction. The main host defense mechanisms against this yeast are engulfment and the production of reactive oxygen molecules by macrophages through Dectin-1 and the Mannose Receptor, two macrophage receptors for Candida albicans cell wall sugars. However, the contribution of these two receptors remains unclear. In our animal experiments, the lack of Dectin-1 in macrophages renders the animals more susceptible to gastrointestinal infection with Candida albicans, demonstrating the essential role of Dectin-1 in antifungal defense. In addition, our experiments established that the interaction between Dectin-1 and Mannose Receptor is important to orchestrate the host antifungal defense. Thus, Candida albicans clearance would be improved by Dectin-1 and Mannose Receptor up-regulation. Interestingly, we had established that the expression of these two receptors was increased by IL-13 through the activation of the nuclear receptor PPARγ, suggesting that PPARγ could be a therapeutic target to eliminate fungal infection. This paper, which highlights a new area of application of PPARγ ligands in infectious diseases, hence heralds the emergence of a new therapeutic strategy against fungal infection in severely immunocompromised patients or those with metabolic diseases.

17 November 2011 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
GCGrégoire Chevalier
Grégoire Chevalier
ESElsa Suberbielle
Elsa Suberbielle
CMCéline MONNET
Céline MONNET
VDValérie Duplan
Valérie Duplan
GMGuillaume Martin-Blondel
Guillaume Martin-Blondel
DGDaniel Gonzalez-Dunia
Daniel Gonzalez-Dunia
Following infection of the central nervous system (CNS), the immune system is faced with the challenge of eliminating the pathogen without causing significant damage to neurons, which have limited capacities of renewal. In particular, it was thought that neurons were protected from direct attack by cytotoxic T lymphocytes (CTL) because they do not express major histocompatibility class I (MHC I) molecules, at least at steady state. To date, most of our current knowledge on the specifics of neuron-CTL interaction is based on studies artificially inducing MHC I expression on neurons, loading them with exogenous peptide and applying CTL clones or lines often differentiated in culture. Thus, much remains to be uncovered regarding the modalities of the interaction between infected neurons and antiviral CD8 T cells in the course of a natural disease. Here, we used the model of neuroinflammation caused by neurotropic Borna disease virus (BDV), in which virus-specific CTL have been demonstrated as the main immune effectors triggering disease. We tested the pathogenic properties of brain-isolated CD8 T cells against pure neuronal cultures infected with BDV. We observed that BDV infection of cortical neurons triggered a significant up regulation of MHC I molecules, rendering them susceptible to recognition by antiviral CTL, freshly isolated from the brains of acutely infected rats. Using real-time imaging, we analyzed the spatio-temporal relationships between neurons and CTL. Brain-isolated CTL exhibited a reduced mobility and established stable contacts with BDV-infected neurons, in an antigen- and MHC-dependent manner. This interaction induced rapid morphological changes of the neurons, without immediate killing or impairment of electrical activity. Early signs of neuronal apoptosis were detected only hours after this initial contact. Thus, our results show that infected neurons can be recognized efficiently by brain-isolated antiviral CD8 T cells and uncover the unusual modalities of CTL-induced neuronal damage. When a virus infects the brain, it is important to quickly block viral replication without causing excessive damage to neurons, which are not easily renewed. Cytotoxic T lymphocytes (CTL) are one of the main actors for virus elimination. However, the question of whether CTL are indeed capable of destroying infected neurons remains controversial. For this work, we analyzed the characteristics of interactions between infected neurons and CTL using neurotropic Borna disease virus (BDV). This virus infects neurons and triggers severe inflammation in the brain. We isolated CTL directly from the brains of rats infected with BDV and analyzed their interaction with primary cultures of neurons. Using live-cell fluorescence microscopy, we observed that CTL were arrested upon encounter with infected neurons and that they established stable contacts with them. Thereafter, infected neurons exhibited rapid changes in permeability but remained alive and electrically active for several hours, before ultimately being destroyed. Our study shows that neurons can indeed be recognized by CTL, an important observation for a better understanding of the physiopathology of virus-induced brain inflammation. In addition, it reveals that neurons are relatively resistant to CTL-induced killing, which may open a window of opportunity for new treatments.